Showing results (61-70 of 77) with videos related to
Sort By:
Pageof 8
Annals of the Academy of Medicine, Singapore|September 10, 2025
Evaluating the impact of relative dose intensity on efficacy of trastuzumab deruxtecan for metastatic breast cancer in the real-world clinical settingHan Yi Lee, Vivianne Shih, Jack Junjie Chan, et al.Journal for Immunotherapy of Cancer|February 8, 2019
Prognostic value of CD8 + PD-1+ immune infiltrates and PDCD1 gene expression in triple negative breast cancerJoe Yeong, Jeffrey Chun Tatt Lim, Bernett Lee, et al.The New England Journal of Medicine|September 16, 2024
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast CancerPeter Schmid, Javier Cortes, Rebecca Dent, et al.The Lancet. Oncology|August 13, 2013
Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trialDavid Cameron, Julia Brown, Rebecca Dent, et al.Breast Cancer Research and Treatment|January 10, 2018
Association of mitochondrial DNA content in peripheral blood with cancer-related fatigue and chemotherapy-related cognitive impairment in early-stage breast cancer patients: a prospective cohort studyJung-Woo Chae, Peh Siang Chua, Terence Ng, et al.Frontiers in Neurology|January 11, 2021
Impact of Cryotherapy on Sensory, Motor, and Autonomic Neuropathy in Breast Cancer Patients Receiving Paclitaxel: A Randomized, Controlled TrialDing Quan Ng, Chia Jie Tan, Boon Chua Soh, et al.Neuro-Oncology|August 21, 2015
Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancerTerence Ng, Shu Mei Teo, Hui Ling Yeo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2023
First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker ResultsPeter Schmid, Nicholas C Turner, Carlos H Barrios, et al.JCO Global Oncology|October 5, 2020
Understanding the Psychological Impact of COVID-19 Pandemic on Patients With Cancer, Their Caregivers, and Health Care Workers in SingaporeKennedy Yao Yi Ng, Siqin Zhou, Sze Huey Tan, et al.The New England Journal of Medicine|February 9, 2022
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast CancerPeter Schmid, Javier Cortes, Rebecca Dent, et al.Pageof 8